n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with bn 52020 in 1 studies
| Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (bn 52020) | Trials (bn 52020) | Recent Studies (post-2010) (bn 52020) |
|---|---|---|---|---|---|
| 79 | 1 | 16 | 14 | 0 | 5 |
| Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | bn 52020 (IC50) |
|---|---|---|---|
| Glycine receptor subunit alpha-1 | Homo sapiens (human) | 1.8032 | |
| Glycine receptor subunit alpha-2 | Homo sapiens (human) | 2.0476 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 3.8 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 3.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and bn 52020
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |